Publicacions
-
Mata A, Vila-Planas A, Solsona-Pujol A, Dueña J, Torrents M, Izquierdo-García E, Pastor-Anglada M, Perez-Torras S and Terrazas M.
RNase H-sensitive multifunctional ASO-based constructs as promising tools for the treatment of multifactorial complex pathologies
BIOORGANIC CHEMISTRY . 150: 107595-107595. Nº de cites: 9
-
Pastor-Anglada M, Mata A and Perez-Torras S.
Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 23(15): 8770. Nº de cites: 10
-
Boces-Pascual, C, Mata A, Martin-Satue, M, Boix, L, Gironella, M, Pastor-Anglada M and Perez-Torras S.
OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1
CELLULAR AND MOLECULAR LIFE SCIENCES . 78(23): 7505-7518. Nº de cites: 6
-
Pena-Rodríguez E, Mata A, García-Vega L, Pérez-Torras S and Fernández-Campos F.
The Physicochemical, Biopharmaceutical, and In Vitro Efficacy Properties of Freeze-Dried Dexamethasone-Loaded Lipomers.
Pharmaceutics . 13(8): 1322. Nº de cites: 9
-
Mata A, Calvo E, Marsal-Beltran A, Medina-Pulido L, Lozano JJ, Ormazabal-Herrero A, Balaguer-Román A, Frutos MD, Artuch-Iriberri R, Cámara Y, Martí R, Rodrigues CMP, Castro RE, Hernández-Alvarez MI, Ramos-Molina B, Pastor-Anglada M, Fernández-Veledo S and Perez-Torras S.
Equilibrative nucleoside transporter 1 deficiency protects against diet-induced MASLD and is stage-associated in human liver disease.
METABOLISM-CLINICAL AND EXPERIMENTAL . 183: 156710-156710.